DOUGLASS T. DOMOTO, M.D.; WENDY W. BROWN, M.D.; PAULA BRUGGENSMITH, M.D.
Two patients with renal failure developed N-acetylprocainamide toxicity while receiving procainamide. Treatment consisted of continuous arteriovenous hemofiltration in one and hemodialysis followed by continuous arteriovenous hemodiafiltration in the other. The efficacy of these treatments was compared with the efficacy of three-times-weekly hemodialysis as used in two patients on chronic hemodialysis who had elevated N-acetylprocainamide levels. Continuous methods produced a more rapid reduction in N-acetylprocainamide levels than intermittent hemodialysis.
Learn more about subscription options.
Register Now for a free account.
DOMOTO DT, BROWN WW, BRUGGENSMITH P. Removal of Toxic Levels of N-Acetylprocainamide with Continuous Arteriovenous Hemofiltration or Continuous Arteriovenous Hemodiafiltration. Ann Intern Med. 1987;106:550–552. doi: 10.7326/0003-4819-106-4-550
Download citation file:
Published: Ann Intern Med. 1987;106(4):550-552.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only